跳至主要内容
临床试验/CTRI/2023/07/055053
CTRI/2023/07/055053尚未招募2 期

Clinical evaluation of sarpagandha ghanvati in hypertension

MANISHA1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年7月17日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
a) Headache

研究概览

简要总结

This study is a open label clinical trial to determine the efficacy of sarpagandha ghanvati in hypertension for the age group between 18 to 70 years for 45 days.Study will be conducted at UAU, Gurukul Campus, Haridwar on 40 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Kayachikitsa. Assessment will be done at weekly interval and result obtained will be analyzed using appropriate tests

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex with age between 18-70 years Patients having Systolic Blood Pressure is more than 140 and less than 180 mm of Hg Patients having Diastolic Blood Pressure is more than 90 and less than or equal to 110 mm of Hg.

排除标准

  • Patients of either sex below 18 years & above 70 years will be excluded from the study Patients having Systolic Blood Pressure is more than 180mm of Hg Patients having Diastolic Blood Pressure is more than 110mmHg Patients suffering from serious comorbidities like Renal failure, Coronaryartery disease, endocrinal disorder, congestive heart disease Pregnant woman.

结局指标

主要结局

a) Headache

时间窗: Assessment willl be done weekly for 8 weeks

b) Giddiness

时间窗: Assessment willl be done weekly for 8 weeks

c) Palpitations

时间窗: Assessment willl be done weekly for 8 weeks

d) Breathlessness

时间窗: Assessment willl be done weekly for 8 weeks

e) Insomnia

时间窗: Assessment willl be done weekly for 8 weeks

次要结局

  • 1. systolic blood pressure(2. diastolic blood pressure)

研究者

发起方
MANISHA
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验